CureVachttps://curevac.com/

Your landing page’s weakest score is Value props.

How CureVac ranks

  1. 1.Moderna62
  2. 2.BioNTech57
  3. 3.Gritstone bio57
  4. 4.CureVac49
  5. 5.TareBio44
Fix Value props
49Growth scoreupdated

category scores

Value props38CTA42
category scoresShowHide
Value props38CTA42

Value props

38Poor

Title, subtitle, hero — do they sell the product's true value?

CureVac’s headline vagueBioNTech successfully closed the acquisition of CureVac.With this, CureVac is now part of the BioNTech Group (Nasdaq: BNTX), a global next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases.

Working

  • States the acquisition plainly, no ambiguity
  • Names disease focus: cancer, serious diseases
  • Gives clear next-step links to BioNTech

Could improve

  • No value prop for CureVac's mRNA science
  • Zero numbers, proof points, or pipeline facts
  • "Next generation" is buzzword filler

CTA

42Poor

Copy, size, verb, cost-feel — does the primary CTA earn the click?

Read more
CureVac
Moderna
BioNTech
Gritstone bio

Problems

  • desktop fold has no button at all
  • 'Read more' promises no payoff
  • desktop links are bare URLs
  • labels differ desktop vs mobile

Information hierarchy

48Poor

Does the design help or inhibit what the page is trying to say?

CureVac desktop capture for Information hierarchy

What works

What to improve

Trust

55Fair

Proof that the product is real, competent, and safe to try.

CureVac desktop capture for Trust

How CureVac compares

Trust read

Mobile web

62Fair

The phone experience as a first-class citizen.

CureVac mobile capture for Mobile web

What works

What to improve